NPCE

NASDAQ 已收盘

NeuroPace

14.25 USD
-0.34-2.33%
盘后 14.26 0.00%
2026-09-15
市值
$483.97M
市盈率
EPS
-0.57
股息率
52 周区间
9.22 – 19.60
成交量
96.84K
Beta
1.95
目标价
20.22
52W 低 9.2252W 高 19.60
价格走势

公司简介

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programmin...